insights_auto
Why is IKT up 3.14%?
Dive Deeperchevron_right
IKT:NASDAQ
Inhibikase Therapeutics Inc
$1.97
arrow_upward
+3.14%(+0.060) 1D
Oct 9, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IKT...
Open
$1.90
High
$1.98
Low
$1.87
Mkt. cap
274.89M
Avg. vol.
518.16K
Volume
0.00
52-wk high
$2.61
52-wk low
$1.33
EPS
-$0.44
Beta
0.89
Shares outstanding
139.54M
No. of employees
35
Open
$1.90
High
$1.98
Low
$1.87
Mkt. cap
274.89M
Avg. vol.
518.16K
Volume
0.00
52-wk high
$2.61
52-wk low
$1.33
EPS
-$0.44
Beta
0.89
Shares outstanding
139.54M
No. of employees
35
News stories
From web sources and news partners
CryptoRank
·
16 minutes ago
TruGolf completes Polymath acquisition, bringing tokenization infrastructure into Nasdaq-listed company
TradingView
·
39 minutes ago
Key facts: Goldman, Barclays Back NASDAQ:PLTR; CTO Defends Maven AI
The Dark Side Of The Boom
·
8 minutes ago
Goldman: The Index Is Calm, but the Positioning Underneath It Is Getting Violent
Bloomberg.com
·
9 hours ago
Oil Rises on Mideast Attacks, Dollar Edges Higher: Markets Wrap
About Inhibikase Therapeutics Inc
CEO-
Employees35
Founded2008
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteinhibikase.com